Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions
CITATION: Zitha, E., Chiliza, B., Muloiwa, R. & Lehloenya, R. 2014. Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions. Clinical and Translational Allergy, 4(Suppl 3):P95, doi:10.1186/2045-7022-4-S3-P95.
The original publication is available at http://www.ctajournal.com/content/4/S3/P95
Background Little is known on the short-term or medium-term psychological and psychiatric sequelae following Stevens Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and drug reaction with eosinophilia and systemic symptoms (DRESS). Based on this we did a prospective study designed to assess anxiety and depression in patients with severe cutaneous adverse drug reactions by indicating higher Hospital anxiety and depression scale (HADS).